Document Detail

Feasibility, safety, and morphologic predictors of outcome of repeat percutaneous balloon mitral commissurotomy.
MedLine Citation:
PMID:  15820172     Owner:  NLM     Status:  MEDLINE    
Early and mid-term results of repeat percutaneous balloon mitral commissurotomy (PBMC) were analyzed in 35 patients with symptomatic valvular restenosis: 12 patients (34%) after first successful PBMC and 23 patients (66%) after successful surgical closed mitral commissurotomy. Twenty-one patients had bilateral fused commissures, and 14 patients had unilateral or bilateral split commissures. Mitral valve area gain was significantly greater in the group with fused commissures compared with the group with split commissures (0.6 +/- 0.2 vs 0.3 +/- 0.2 cm(2), respectively, p = 0.04).
Yoav Turgeman; Shaul Atar; Khalid Suleiman; Alexander Feldman; Lev Bloch; Mohamed Jabaren; Tiberio Rosenfeld
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  95     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-04-11     Completed Date:  2005-05-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  989-91     Citation Subset:  AIM; IM    
Department of Cardiology, Ha'Emek Medical Center, Afula, Israel. <>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Balloon Dilatation / adverse effects*,  methods*
Cardiac Surgical Procedures / adverse effects*,  methods*
Middle Aged
Mitral Valve / anatomy & histology,  pathology
Mitral Valve Stenosis / surgery*
Risk Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Predicting coronary heart disease risk using multiple lipid measures.
Next Document:  Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamb...